Table 5.

The effects of MKD in focal vs generalised epilepsy syndromes

	Focal (%) n = 26	Generalised (%) n = 14	χ2df	p
Seizure improvement	65.4	50	0.881	0.350
> 50% improvement	38.5	35.7	0.031	0.866
Seizure freedom	15.4	7.1	2.311	0.129
Seizure worsening	34.6	21.4	0.741	0.391
Other benefit	57.7	42.9	0.781	0.376

The results of the Chi-square test with unadjusted p values are described above

For retention rates, see Fig. 2. Out of the 28 who did not adhere to MKD for 12 months, reasons reported for discontinuation of diet were as follows: diet too restrictive (8/28, 25%), side effects (10/28, 35.7%), worsening of seizures (4/28, 14.3%), and lack of benefit to seizure frequency (12/28, 42.9%)